Alzheimer’s Disease (AD) continues to be a pressing global health concern, affecting millions of people worldwide. Reduced cholinergic transmission has been identified as a crucial neurotransmitter dysfunction in AD. In light of this, researchers have been investigating potential treatments such… Continue Reading →
© 2024 Christophe Garon — Powered by WordPress
Theme by Anders Noren — Up ↑